The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9

European Journal of Immunology
V BraudA McMichael

Abstract

Human histocompatibility leukocyte antigen E (HLA-E) and mouse major histocompatibility complex (MHC) class Ib antigen, Qa-1, share the same substitutions at two normally conserved positions 143 and 147, which are likely to affect binding of the C terminus of peptides. Qa-1 is able to bind a peptide derived from the leader sequence of H-2 D and H-2 L molecules. We developed a peptide binding assay in vitro to compare the binding specificity of HLA-E with the mouse MHC class Ib molecule Qa-1. We demonstrate that HLA-E binds, although poorly, the peptide which binds to Qa-1 and that it also binds nonamer signal sequence-derived peptides from human MHC class I molecules. Using alanine and glycine substitutions, we could define primary anchor residues at positions 2 and 9 and secondary anchor residues at position 7 and possibly 3.

References

Jan 1, 1991·Annual Review of Immunology·K Fischer LindahlC R Wang
Feb 1, 1989·The Journal of Experimental Medicine·B H KollerH T Orr
Jul 14, 1995·Science·P A SielingP J Brennan
Jan 1, 1994·Annual Review of Immunology·S M ShawarR R Rich
Mar 1, 1996·Current Biology : CB·M DiehlH G Rammensee
Oct 1, 1995·Immunological Reviews·M J SoloskiJ Forman
Jun 1, 1996·Immunological Reviews·L L Lenz, M J Bevan

❮ Previous
Next ❯

Citations

Mar 29, 2002·European Journal of Immunology·Pilar GarcíaMiguel López-Botet
May 30, 1998·Protein Science : a Publication of the Protein Society·C A O'CallaghanE Y Jones
Jul 30, 2011·Archivum Immunologiae Et Therapiae Experimentalis·Milena Iwaszko, Katarzyna Bogunia-Kubik
Nov 2, 2004·Immunogenetics·Evan HermelCarla J Aldrich
Feb 14, 2008·Immunogenetics·Keith T BallingallDeclan J McKeever
Mar 19, 2009·Medical Molecular Morphology·Satoshi YamagiwaTakafumi Ichida
May 4, 2004·Human Immunology·Hui Lin ChuaZacharie Brahmi
Sep 6, 2002·Journal of Immunological Methods·David S J AllanAndrew J McMichael
Sep 9, 1999·Journal of Reproductive Immunology·F NavarroM López-Botet
Sep 9, 1999·Journal of Reproductive Immunology·C CantoniR Biassoni
Sep 9, 1999·Journal of Reproductive Immunology·I Khalil-DaherN Rouas-Freiss
Jun 29, 2000·Immunology Today·R J AllcockP Price
Jun 26, 1998·Immunology Today·F PocciaM Malkovsky
Feb 5, 2000·Human Immunology·M Valés-GómezJ Strominger
Feb 5, 2000·Human Immunology·M López-BotetM de Miguel
Mar 3, 2001·Current Opinion in Immunology·M J Soloski
Feb 27, 1999·Current Opinion in Immunology·V M BraudA J McMichael
Feb 1, 2003·Trends in Cell Biology·Andreas Weihofen, Bruno Martoglio
Jan 8, 2004·Seminars in Cancer Biology·Mirjana Urosevic, Reinhard Dummer
May 4, 2001·Microbes and Infection·P Le Bouteiller, C Solier
May 30, 2001·Current Opinion in Microbiology·B T CooksonS L Rassoulian Barrett
Mar 5, 2003·Trends in Immunology·Lorenzo MorettaMaria Cristina Mingari
Nov 26, 2002·Tissue Antigens·W T N SwelsenE M van den Berg-Loonen
Mar 22, 2002·Nature Reviews. Immunology·A Cerwenka, L L Lanier
Jun 2, 2005·Nature Reviews. Immunology·John R Rodgers, Richard G Cook
Dec 21, 2004·Nature Reviews. Microbiology·Melissa B Lodoen, Lewis L Lanier
Aug 30, 2000·Proceedings of the Society for Experimental Biology and Medicine·M J SoloskiS L Wooden
Jun 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Marloes GoodenThorbald van Hall
Sep 9, 1998·The Journal of Experimental Medicine·Z KurepaJ Forman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.